Amylon Therapeutics wins Startup Slam Competition at BIO-Europe® Berlin
Startup Slam sponsor Johnson & Johnson Innovation recognise high calibre of diverse European entries
09-Nov-2017 -
Amylon Therapeutics was today announced as the winner of the Startup Slam competition at this year’s BIO-Europe® 2017 annual conference in Berlin. Thomas de Vlaam, CEO and founder of Amylon Therapeutics, will receive a complimentary registration to BIO-Europe® Spring 2018 from EBD Group and the ...
central nervous system
genetic disorders
genetics
+7